Go Pro

Merit Medical Systems (MMSI) Competitors

Merit Medical Systems logo
$90.50 -0.70 (-0.77%)
Closing price 08/13/2026 04:00 PM Eastern
Extended Trading
$90.54 +0.03 (+0.04%)
As of 08/13/2026 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MMSI vs. ADUS, HQY, MEDP, AMN, and ELV

Should you buy Merit Medical Systems stock or one of its competitors? Merit Medical Systems's main competitors and comparable companies include Addus HomeCare (ADUS), HealthEquity (HQY), Medpace (MEDP), AMN Healthcare Services (AMN), and Elevance Health (ELV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Merit Medical Systems compare to Addus HomeCare?

Addus HomeCare (NASDAQ:ADUS) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations and valuation.

Merit Medical Systems has a net margin of 9.22% compared to Addus HomeCare's net margin of 7.13%. Merit Medical Systems' return on equity of 13.75% beat Addus HomeCare's return on equity.

Company Net Margins Return on Equity Return on Assets
Addus HomeCare7.13% 9.96% 7.62%
Merit Medical Systems 9.22%13.75%8.10%

Addus HomeCare has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.49, indicating that its stock price is 51% less volatile than the broader market.

Addus HomeCare presently has a consensus target price of $130.88, indicating a potential upside of 11.30%. Merit Medical Systems has a consensus target price of $100.00, indicating a potential upside of 10.50%. Given Addus HomeCare's stronger consensus rating and higher probable upside, equities analysts plainly believe Addus HomeCare is more favorable than Merit Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Addus HomeCare
1 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.73
Merit Medical Systems
0 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.67

95.4% of Addus HomeCare shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 4.1% of Addus HomeCare shares are owned by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Merit Medical Systems has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Addus HomeCare$1.42B1.54$95.91M$5.7020.63
Merit Medical Systems$1.58B3.42$128.49M$2.4237.40

In the previous week, Merit Medical Systems had 12 more articles in the media than Addus HomeCare. MarketBeat recorded 16 mentions for Merit Medical Systems and 4 mentions for Addus HomeCare. Merit Medical Systems' average media sentiment score of 1.23 beat Addus HomeCare's score of 0.90 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Addus HomeCare
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Merit Medical Systems
8 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Merit Medical Systems beats Addus HomeCare on 11 of the 17 factors compared between the two stocks.

How does Merit Medical Systems compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, institutional ownership, valuation, risk, analyst recommendations and earnings.

In the previous week, Merit Medical Systems had 4 more articles in the media than HealthEquity. MarketBeat recorded 16 mentions for Merit Medical Systems and 12 mentions for HealthEquity. Merit Medical Systems' average media sentiment score of 1.23 beat HealthEquity's score of 1.02 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
HealthEquity
6 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Merit Medical Systems
8 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

HealthEquity presently has a consensus price target of $110.93, indicating a potential upside of 5.06%. Merit Medical Systems has a consensus price target of $100.00, indicating a potential upside of 10.50%. Given Merit Medical Systems' higher possible upside, analysts plainly believe Merit Medical Systems is more favorable than HealthEquity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HealthEquity
1 Sell rating(s)
1 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.77
Merit Medical Systems
0 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.67

HealthEquity has a net margin of 17.25% compared to Merit Medical Systems' net margin of 9.22%. HealthEquity's return on equity of 14.75% beat Merit Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
HealthEquity17.25% 14.75% 9.22%
Merit Medical Systems 9.22%13.75%8.10%

HealthEquity has higher earnings, but lower revenue than Merit Medical Systems. Merit Medical Systems is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HealthEquity$1.31B6.72$215.20M$2.6739.55
Merit Medical Systems$1.58B3.42$128.49M$2.4237.40

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 1.6% of HealthEquity shares are held by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

HealthEquity has a beta of 0.21, indicating that its stock price is 79% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.49, indicating that its stock price is 51% less volatile than the broader market.

Summary

HealthEquity beats Merit Medical Systems on 10 of the 16 factors compared between the two stocks.

How does Merit Medical Systems compare to Medpace?

Merit Medical Systems (NASDAQ:MMSI) and Medpace (NASDAQ:MEDP) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

In the previous week, Medpace had 2 more articles in the media than Merit Medical Systems. MarketBeat recorded 18 mentions for Medpace and 16 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.23 beat Medpace's score of 0.75 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Merit Medical Systems
8 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Medpace
11 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Merit Medical Systems has a beta of 0.49, indicating that its stock price is 51% less volatile than the broader market. Comparatively, Medpace has a beta of 1.15, indicating that its stock price is 15% more volatile than the broader market.

99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 0.7% of Merit Medical Systems shares are held by company insiders. Comparatively, 20.5% of Medpace shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Merit Medical Systems currently has a consensus target price of $100.00, indicating a potential upside of 10.50%. Medpace has a consensus target price of $584.18, indicating a potential upside of 0.38%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, equities research analysts plainly believe Merit Medical Systems is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems
0 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.67
Medpace
0 Sell rating(s)
10 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.23

Medpace has higher revenue and earnings than Merit Medical Systems. Medpace is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Merit Medical Systems$1.58B3.42$128.49M$2.4237.40
Medpace$2.53B6.42$451.12M$17.0634.11

Medpace has a net margin of 17.67% compared to Merit Medical Systems' net margin of 9.22%. Medpace's return on equity of 110.15% beat Merit Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Merit Medical Systems9.22% 13.75% 8.10%
Medpace 17.67%110.15%24.84%

Summary

Medpace beats Merit Medical Systems on 10 of the 16 factors compared between the two stocks.

How does Merit Medical Systems compare to AMN Healthcare Services?

Merit Medical Systems (NASDAQ:MMSI) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, media sentiment, dividends, valuation and earnings.

Merit Medical Systems has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Merit Medical Systems$1.58B3.42$128.49M$2.4237.40
AMN Healthcare Services$2.73B0.49-$95.70M$2.6812.85

Merit Medical Systems currently has a consensus target price of $100.00, suggesting a potential upside of 10.50%. AMN Healthcare Services has a consensus target price of $30.86, suggesting a potential downside of 10.40%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, equities research analysts plainly believe Merit Medical Systems is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems
0 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.67
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22

99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 0.7% of Merit Medical Systems shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, AMN Healthcare Services had 2 more articles in the media than Merit Medical Systems. MarketBeat recorded 18 mentions for AMN Healthcare Services and 16 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.23 beat AMN Healthcare Services' score of 0.61 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Merit Medical Systems
8 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
5 Very Positive mention(s)
4 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Merit Medical Systems has a beta of 0.49, meaning that its share price is 51% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, meaning that its share price is 60% less volatile than the broader market.

Merit Medical Systems has a net margin of 9.22% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat Merit Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Merit Medical Systems9.22% 13.75% 8.10%
AMN Healthcare Services 3.06%19.92%5.93%

Summary

Merit Medical Systems beats AMN Healthcare Services on 11 of the 16 factors compared between the two stocks.

How does Merit Medical Systems compare to Elevance Health?

Merit Medical Systems (NASDAQ:MMSI) and Elevance Health (NYSE:ELV) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

Merit Medical Systems presently has a consensus price target of $100.00, suggesting a potential upside of 10.50%. Elevance Health has a consensus price target of $440.90, suggesting a potential upside of 10.57%. Given Elevance Health's higher probable upside, analysts clearly believe Elevance Health is more favorable than Merit Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems
0 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.67
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

Merit Medical Systems has a net margin of 9.22% compared to Elevance Health's net margin of 2.47%. Elevance Health's return on equity of 14.64% beat Merit Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Merit Medical Systems9.22% 13.75% 8.10%
Elevance Health 2.47%14.64%5.22%

Elevance Health has higher revenue and earnings than Merit Medical Systems. Elevance Health is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Merit Medical Systems$1.58B3.42$128.49M$2.4237.40
Elevance Health$199.13B0.43$5.66B$22.5017.72

Merit Medical Systems has a beta of 0.49, meaning that its share price is 51% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market.

In the previous week, Merit Medical Systems had 8 more articles in the media than Elevance Health. MarketBeat recorded 16 mentions for Merit Medical Systems and 8 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.44 beat Merit Medical Systems' score of 1.23 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Merit Medical Systems
8 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Elevance Health
6 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 0.7% of Merit Medical Systems shares are held by company insiders. Comparatively, 0.3% of Elevance Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Merit Medical Systems and Elevance Health tied by winning 8 of the 16 factors compared between the two stocks.

Get Merit Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for MMSI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MMSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MMSI vs. The Competition

MetricMerit Medical SystemsHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$5.40B$5.95B$7.07B$13.00B
Dividend YieldN/A1.76%2.58%10.72%
P/E Ratio37.4026.47269.6325.21
Price / Sales3.4240.64596.7299.91
Price / Cash15.5133.5970.5350.75
Price / Book3.225.9013.116.24
Net Income$128.49M$148.67M$3.45B$347.70M
7 Day Performance1.64%1.86%0.78%0.87%
1 Month Performance27.43%4.64%1.45%0.90%
1 Year Performance6.20%8.94%67.07%20.13%

Merit Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MMSI
Merit Medical Systems
3.5307 of 5 stars
$90.50
-0.8%
$100.00
+10.5%
+5.0%$5.40B$1.58B37.407,500
ADUS
Addus HomeCare
3.4369 of 5 stars
$110.78
-5.1%
$131.50
+18.7%
+1.1%$2.03B$1.42B20.0950,659
HQY
HealthEquity
3.9904 of 5 stars
$103.51
-0.8%
$110.93
+7.2%
+18.3%$8.65B$1.31B38.772,814
MEDP
Medpace
3.5391 of 5 stars
$570.34
-0.5%
$584.18
+2.4%
+24.3%$15.95B$2.53B33.496,200
AMN
AMN Healthcare Services
2.0355 of 5 stars
$32.21
-2.4%
$29.00
-10.0%
+84.8%$1.25B$3.42BN/A2,664

Related Companies and Tools


This page (NASDAQ:MMSI) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners